Genotype-Related Efficacy and Adverse Effects of Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder. Precision Medicine Communications, [S. l.], v. 2, n. 1, p. 27–42, 2022. DOI: 10.55627/pmc.002.01.0044. Disponível em: https://rootspress.org/journals/index.php/PMC/article/view/44. Acesso em: 8 may. 2026.